Skip to content
Lower risk Drug recall · FDA · Published March 7, 2024

Teva Tri-Lo-Sprintec Tablets Recall: Failed Dissolution Specifications

Teva recalls Tri-Lo-Sprintec birth control tablets due to failed dissolution specifications. This may affect product effectiveness. Check NDC 0093-2140-62 and lot numbers for affected items.

🇺🇸 FDA recall #D-0428-2024DrugTeva ›
Take action

Contact the company

Recalling firmTeva Pharmaceuticals USA, Inc400 Interpace Pkwy Bldg A · Parsippany, NJ 07054-1120
✎ GovInfoNow plain-language explainer

Teva is recalling Tri-Lo-Sprintec birth control tablets that failed dissolution specifications. This means the tablets might not work as intended, potentially affecting birth control effectiveness. Read more at govinfonow.com/recall/32780-teva-tri-lo-sprintec-tablets-recall-failed-dissolution-specifications.

Source Summary by GovInfoNow · govinfonow.com/recall/32780-teva-tri-lo-sprintec-tablets-recall-failed-dissolution-specifications · Updated August 17, 2026 · FDA enforcement record: FDA #D-0428-2024

Cite this page

“Teva Tri-Lo-Sprintec Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32780-teva-tri-lo-sprintec-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-0428-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0428-2024%22&limit=1).

The FDA announced on March 7, 2024, that Teva Pharmaceuticals USA, Inc. is recalling Tri-Lo-Sprintec tablets due to failed dissolution specifications. The recall affects 92,676 cartons distributed nationwide.

How to tell if you have it

  • Brand: Teva
  • Product: Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen
  • NDC: 0093-2140-62
  • Lot codes: 100039678, 100038111, 100042277
  • Expiration dates: 04/31/2024, 07/31/2024

The hazard

The tablets failed dissolution specifications. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Teva Pharmaceuticals USA, Inc. has 59 other recalls on record since April 2, 2012. Recent Teva recalls include traZODone 50mg tablets recalled on August 24, 2026, for foreign tablet risk, and Octreotide Acetate 30mg Kit recalled on April 24, 2026, due to sterility risks. Other recent recalls of similar products include Viatris Xanax XR 3mg Tablets Recall (March 17, 2026), Novartis Recalls Diovan 160mg Tablets (August 4, 2026), and Inventia Healthcare Chlorthalidone Tablets Recall (June 5, 2026).

How to tell if you have this one

Check for NDC 0093-2140-62 on the packaging. Affected lots include 100039678 (expiring 04/31/2024) and 100038111, 100042277 (expiring 07/31/2024).

  • Brand
    Teva
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for NDC 0093-2140-62 and lot numbers 100039678, 100038111, or 100042277 on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 12 months after the firm started it.

1. Firm started the recall: Mar 7, 202412. FDA classified it Class II: Mar 28, 202423. Published in FDA’s Enforcement Report: Apr 3, 202434. FDA terminated the recall: Mar 6, 2025420242025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is there a risk of serious injury from this product?

No, the recall is for potential reduced effectiveness, not a safety hazard that causes injury.

Similar recalls

Other Teva recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0428-2024 (March 7, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0428-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA